Published in Phys Med Biol on September 01, 1995
The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect (2006) 1.91
Cumulative exposure to lead in relation to cognitive function in older women. Environ Health Perspect (2008) 1.87
Dietary and environmental determinants of blood and bone lead levels in lactating postpartum women living in Mexico City. Environ Health Perspect (1996) 1.48
Prenatal organochlorine exposure and behaviors associated with attention deficit hyperactivity disorder in school-aged children. Am J Epidemiol (2010) 1.39
Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes. Environ Health Perspect (2000) 1.35
Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes. Environ Health Perspect (2001) 1.33
Associations of lead biomarkers with renal function in Korean lead workers. Occup Environ Med (2003) 1.29
Associations of tibial lead levels with BsmI polymorphisms in the vitamin D receptor in former organolead manufacturing workers. Environ Health Perspect (2000) 1.29
Interrelations of lead levels in bone, venous blood, and umbilical cord blood with exogenous lead exposure through maternal plasma lead in peripartum women. Environ Health Perspect (2001) 1.22
Prenatal organochlorine exposure and measures of behavior in infancy using the Neonatal Behavioral Assessment Scale (NBAS). Environ Health Perspect (2008) 1.11
Cumulative lead dose and cognitive function in older adults. Epidemiology (2009) 1.07
Predictors of serum dioxin levels among adolescent boys in Chapaevsk, Russia: a cross-sectional pilot study. Environ Health (2005) 1.07
Gender and race/ethnicity differences in lead dose biomarkers. Am J Public Health (2008) 1.06
Longitudinal changes in bone lead levels: the VA Normative Aging Study. J Occup Environ Med (2011) 1.06
Lead levels and ischemic heart disease in a prospective study of middle-aged and elderly men: the VA Normative Aging Study. Environ Health Perspect (2007) 1.03
Neuropsychological measures of attention and impulse control among 8-year-old children exposed prenatally to organochlorines. Environ Health Perspect (2012) 1.02
A delta-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the normative aging study. Environ Health Perspect (2003) 1.02
Plasma organochlorine levels and risk of non-Hodgkin lymphoma in a cohort of men. Epidemiology (2010) 0.99
HFE H63D polymorphism as a modifier of the effect of cumulative lead exposure on pulse pressure: the Normative Aging Study. Environ Health Perspect (2010) 0.99
Air pollution and heart rate variability: effect modification by chronic lead exposure. Epidemiology (2008) 0.98
Associations among lead dose biomarkers, uric acid, and renal function in Korean lead workers. Environ Health Perspect (2005) 0.98
Determinants of bone and blood lead levels among minorities living in the Boston area. Environ Health Perspect (2004) 0.97
Cumulative community-level lead exposure and pulse pressure: the normative aging study. Environ Health Perspect (2007) 0.96
Determinants of bone and blood lead concentrations in the early postpartum period. Occup Environ Med (2000) 0.95
Predictors of dimercaptosuccinic acid chelatable lead and tibial lead in former organolead manufacturing workers. Occup Environ Med (1999) 0.94
Associations of renal function with polymorphisms in the delta-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers. Environ Health Perspect (2003) 0.92
The independent contribution of bone and erythrocyte lead to urinary lead among middle-aged and elderly men: the normative aging study. Environ Health Perspect (1999) 0.90
Bone lead level prediction models and their application to examine the relationship of lead exposure and hypertension in the Third National Health and Nutrition Examination Survey. J Occup Environ Med (2009) 0.89
Associations of bone mineral density and lead levels in blood, tibia, and patella in urban-dwelling women. Environ Health Perspect (2008) 0.89
Bone lead levels are associated with measures of memory impairment in older adults. Neurotoxicology (2009) 0.88
Prenatal organochlorine and methylmercury exposure and memory and learning in school-age children in communities near the New Bedford Harbor Superfund site, Massachusetts. Environ Health Perspect (2014) 0.85
Relationships between lead biomarkers and diurnal salivary cortisol indices in pregnant women from Mexico City: a cross-sectional study. Environ Health (2014) 0.84
Prospective study of blood and tibia lead in women undergoing surgical menopause. Environ Health Perspect (2004) 0.82
In vivo analysis of cadmium in battery workers versus measurements of blood, urine, and workplace air. Occup Environ Med (1997) 0.81
Modifying roles of glutathione S-transferase polymorphisms on the association between cumulative lead exposure and cognitive function. Neurotoxicology (2013) 0.80
Determinants of bone and blood lead levels among teenagers living in urban areas with high lead exposure. Environ Health Perspect (1998) 0.80
Lead exposure and rate of change in cognitive function in older women. Environ Res (2014) 0.80
Effect modification by vitamin D receptor genetic polymorphisms in the association between cumulative lead exposure and pulse pressure: a longitudinal study. Environ Health (2015) 0.79
Prospective cohort study of lead exposure and electrocardiographic conduction disturbances in the Department of Veterans Affairs Normative Aging Study. Environ Health Perspect (2011) 0.79
The association of lead exposure during pregnancy and childhood anthropometry in the Mexican PROGRESS cohort. Environ Res (2016) 0.78
Associations of uric acid with polymorphisms in the delta-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers. Environ Health Perspect (2005) 0.78
Cumulative lead exposure and age at menopause in the Nurses' Health Study cohort. Environ Health Perspect (2014) 0.77
Maternal MTHFR genotype and haplotype predict deficits in early cognitive development in a lead-exposed birth cohort in Mexico City. Am J Clin Nutr (2010) 0.77
Validation of X-ray fluorescence-measured Swine femur lead against atomic absorption spectrometry. Environ Health Perspect (2001) 0.75
Feasibility of a portable X-ray fluorescence device for bone lead measurements of condor bones. Sci Total Environ (2017) 0.75
Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med (1995) 7.62
Diagnosis of Chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction. J Clin Microbiol (1994) 5.61
Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med (1998) 4.51
Class II-independent generation of CD4 memory T cells from effectors. Science (1999) 3.96
The relationship of bone and blood lead to hypertension. The Normative Aging Study. JAMA (1996) 3.87
Cerebellar ataxia and Purkinje cell dysfunction caused by Ca2+-activated K+ channel deficiency. Proc Natl Acad Sci U S A (2004) 2.97
Family study of serum lipids and lipoproteins in coronary heart-disease. Lancet (1973) 2.54
Detection of Chlamydia trachomatis infection in urine samples from men and women by ligase chain reaction. J Clin Microbiol (1995) 2.50
Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC Study. Lancet (1993) 2.28
Chemistry of single-walled carbon nanotubes. Acc Chem Res (2002) 2.10
Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr (2009) 2.07
Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease. J Intern Med (2014) 2.06
Decrease in birth weight in relation to maternal bone-lead burden. Pediatrics (1997) 2.00
Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension: the Normative Aging Study. Am J Epidemiol (2001) 1.97
Inference in randomized studies with informative censoring and discrete time-to-event endpoints. Biometrics (2001) 1.85
The steroidal aromatase inhibitor exemestane prevents bone loss in ovariectomized rats. Bone (2004) 1.84
Race and gender differences in respiratory illness prevalence and their relationship to environmental exposures in children 7 to 14 years of age. Am Rev Respir Dis (1993) 1.82
Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted. J Virol (1998) 1.72
The effectiveness of housing policies in reducing children's lead exposure. Am J Public Health (2001) 1.70
Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. Kidney Int (2007) 1.66
Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men. The normative aging study. Am J Epidemiol (1996) 1.63
A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women. Breast Cancer Res Treat (2009) 1.63
Attentional correlates of dentin and bone lead levels in adolescents. Arch Environ Health (1994) 1.60
Plexin-B semaphorin receptors interact directly with active Rac and regulate the actin cytoskeleton by activating Rho. Curr Biol (2001) 1.59
The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission. J Neurosci (1998) 1.58
A longitudinal study of low-level lead exposure and impairment of renal function. The Normative Aging Study. JAMA (1996) 1.57
Improvements in the calibration of 109Cd K x-ray fluorescence systems for measuring bone lead in vivo. Phys Med Biol (1994) 1.54
Long-term effect of betaine on risk factors associated with the metabolic syndrome in healthy subjects. Eur J Clin Nutr (2010) 1.54
Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults. Heart (2006) 1.53
Low-level lead exposure and renal function in the Normative Aging Study. Am J Epidemiol (1994) 1.51
Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. Neurotoxicol Teratol (1998) 1.50
The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes (1994) 1.49
Dietary and environmental determinants of blood and bone lead levels in lactating postpartum women living in Mexico City. Environ Health Perspect (1996) 1.48
Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr (2001) 1.47
Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. Proc Natl Acad Sci U S A (1999) 1.46
Intake of fatty acids in western Europe with emphasis on trans fatty acids: the TRANSFAIR Study. Eur J Clin Nutr (1999) 1.45
Correlates of fitness for duty in hazardous materials firefighters. Am J Ind Med (1999) 1.44
Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med (1998) 1.38
[Eggs are now out of ban--images and real effects]. Duodecim (1999) 1.38
Fitness for duty evaluations in hazardous materials firefighters. J Occup Environ Med (1998) 1.38
A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect (1995) 1.37
Fragmented condensate ground state of trapped weakly interacting bosons in two dimensions. Phys Rev Lett (2001) 1.36
IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells. Clin Exp Allergy (2008) 1.36
Arsenic in drinking water and incidence of urinary cancers. Epidemiology (1997) 1.35
Automated bone lead analysis by K-x-ray fluorescence for the clinical environment. Basic Life Sci (1990) 1.34
MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. Cell Death Differ (2011) 1.33
Changes in diet in Finland from 1972 to 1992: impact on coronary heart disease risk. Prev Med (1996) 1.33
Age and secular trends in bone lead levels in middle-aged and elderly men: three-year longitudinal follow-up in the Normative Aging Study. Am J Epidemiol (1997) 1.33
Nitrate and nitrite intake and the risk for type 1 diabetes in Finnish children. Childhood Diabetes in Finland Study Group. Diabet Med (1994) 1.32
Lead and hypertension in a sample of middle-aged women. Am J Public Health (1999) 1.32
Lead toxicity in older adults. J Am Geriatr Soc (2000) 1.31
Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serum. Am J Epidemiol (1999) 1.31
Reactive airways dysfunction after exposure to teargas. Lancet (1992) 1.30
Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation (2001) 1.30
Kv7/KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release. J Physiol (2006) 1.27
FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation (1997) 1.26
Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein. J Gene Med (2000) 1.23
Interrelations of lead levels in bone, venous blood, and umbilical cord blood with exogenous lead exposure through maternal plasma lead in peripartum women. Environ Health Perspect (2001) 1.22
Relation of nutrition to bone lead and blood lead levels in middle-aged to elderly men. The Normative Aging Study. Am J Epidemiol (1998) 1.20
Tumor-initiating and promoting activities of di(2-ethylhexyl) phthalate in vivo and in vitro. Environ Health Perspect (1986) 1.19
Electrocardiographic conduction disturbances in association with low-level lead exposure (the Normative Aging Study). Am J Cardiol (1998) 1.19
Infant feeding in Finnish children less than 7 yr of age with newly diagnosed IDDM. Childhood Diabetes in Finland Study Group. Diabetes Care (1991) 1.17
Relations between individual and neighborhood-based measures of socioeconomic position and bone lead concentrations among community-exposed men: the Normative Aging Study. Am J Epidemiol (1999) 1.17
The relationship between bone lead and hemoglobin. JAMA (1994) 1.16
Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol (2000) 1.16
Altered expression of piRNAs and their relation with clinicopathologic features of breast cancer. Clin Transl Oncol (2012) 1.16
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc Natl Acad Sci U S A (1998) 1.15
Identity of the cholesterol-raising factor from boiled coffee and its effects on liver function enzymes. J Lipid Res (1994) 1.15
The influence of bone and blood lead on plasma lead levels in environmentally exposed adults. Environ Health Perspect (1998) 1.15
Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology (2009) 1.14
Long-term efficacy after [E1-, polymerase-] adenovirus-mediated transfer of human acid-alpha-glucosidase gene into glycogen storage disease type II knockout mice. Hum Gene Ther (2001) 1.14
Analysis of chromosomal and organellar DNA of somatic hybrids between Triticum aestiuvm and Haynaldia villosa Schur. Mol Genet Genomics (2001) 1.13
Bone lead measured by X-ray fluorescence: epidemiologic methods. Environ Health Perspect (1995) 1.13
A broad role for the zinc finger protein ZNF202 in human lipid metabolism. J Biol Chem (2000) 1.13
Lead exposure as a risk factor for amyotrophic lateral sclerosis. Neurodegener Dis (2005) 1.13
Treatment of osteoporosis with 1-alpha-hydroxycholecalciferol and calcium. Acta Med Scand (1980) 1.11
Plasma homocysteine and cardiovascular disease mortality. Lancet (1997) 1.10
Influence of apolipoprotein A-1 promoter polymorphism on lipid levels and responses to dietary change in Finnish adults. J Intern Med (1997) 1.09
Location-specific, unequal contribution of the N glycans in simian immunodeficiency virus gp120 to viral infectivity and removal of multiple glycans without disturbing infectivity. J Virol (1998) 1.09
Improved diabetic control and hypocholesterolaemic effect induced by long-term dietary supplementation with guar gum in type 2 (insulin-independent) diabetes. Diabetologia (1981) 1.08
A longitudinal study of chronic lead exposure and physical growth in Boston children. Environ Health Perspect (1995) 1.08
Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153. Neoplasma (2011) 1.08
Selenium metabolism and platelet glutathione peroxidase activity in healthy Finnish men: effects of selenium yeast, selenite, and selenate. Am J Clin Nutr (1991) 1.07
Measurements of pertinent concentrations of oxygen in vivo. Magn Reson Med (1991) 1.06
Residual cognitive deficits 50 years after lead poisoning during childhood. Br J Ind Med (1993) 1.06
Lead poisoning from mobilization of bone stores during thyrotoxicosis. Am J Ind Med (1994) 1.05
Arsenic in drinking water and skin cancers: cell-type specificity (Taiwan, ROC). Cancer Causes Control (2001) 1.05
Effect of low level lead exposure on hyperuricemia and gout among middle aged and elderly men: the normative aging study. J Rheumatol (2000) 1.04
The hypercholesterolaemic factor in boiled coffee is retained by a paper filter. J Intern Med (1991) 1.04